Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 16.85
-0.15 (-0.88%)
At close: Jul 31, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 96.08 million as of July 31, 2026. Its market cap has decreased by -28.49% in one year.
Market Cap
96.08M
Enterprise Value
241.44M
Revenue
275.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
16.85
ChartMarket Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 96.08M, a decrease of -60.04%. That is a compound annual growth rate of -18.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 96.08M | -32.55% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.52B |
| Idorsia | 1.67B |
| Basilea Pharmaceutica AG | 647.06M |
| Newron Pharmaceuticals | 240.10M |
| Santhera Pharmaceuticals Holding AG | 214.16M |
| BioVersys AG | 160.42M |
| Molecular Partners AG | 121.91M |
| MindMaze Therapeutics Holding | 30.22M |